Physician profile
Zachary Robert Leitze
NPI 1053341115
$809,449.25
in general payments reported to CMS, 2019-2025
11 companies · $291K in 2025
The $291K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,911 · 2020: $4,128 · 2021: $24K · 2022: $83K · 2023: $176K · 2024: $222K · 2025: $291K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $502K · Consulting Fee: $175K · Travel and Lodging: $11K · Food and Beverage: $2,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $501,909.87 |
| Consulting Fee | $174,661.56 |
| Travel and Lodging | $10,863.91 |
| Food and Beverage | $2,498.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $762,245.84 | 2020-2025 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System, Catalyst Total Csr |
| Encore Medical, Lp | $32,676.07 | 2019-2025 | Djo Surgical |
| Medacta USA, INC. | $7,255.27 | 2023-2024 | Reverse Shoulder |
| Goode Surgical INC | $4,021.11 | 2019-2023 | |
| Arthrex, INC. | $2,301.40 | 2022-2024 | Arthroplasty Implants Anatomic Total Shoulder Eclipse |
| Stryker Corporation | $353.90 | 2023 | Blueprint Patient Specific Instrumentation, Aequalis Flex Revive, Aequalis Perform |
| Orthalign INC | $345.55 | 2020-2024 | Orthalign Plus |
| Exactech, INC. | $184.44 | 2023 | |
| Shoulder Innovations, INC. | $28.70 | 2025 | Inset System |
| Depuy Synthes Sales INC. | $24.01 | 2020 | |
| Nalu Medical, INC. | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$247,650.23 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Leitze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.